Friday, 5 April 2019

Electronic Pill Market to Observe Strong Development by 2018

Market Scenario
The growing prevalence of gastrointestinal diseases, increasing unhealthy food consumption, increase in research and development activities, growing government reimbursement policies, rising geriatric population, increased need for rapid diagnostics, and adoption of advanced technologies are the key factors for the electronic pill market to grow. However, factors such as bowel obstruction, lack of awareness, capsule retention and high costs are expected to restrict the market growth during the forecast period.
The Global Electronic Pill Market is expected to reach an approximate CAGR of 15% during the forecast period.
The electronic pill is an ingestible capsule that is embedded with sensors and camera. After ingesting the pill, the pill captures several images per second of the gastrointestinal tract which is received by the connected recording device. It is a monitoring system used to monitor temperature, pH, conductivity and dissolved oxygen. Electronic Pills are used for diagnostics of various gastrointestinal tract diseases like colon cancer, colon polyps, gastrointestinal bleeding and other infectious diseases. The increase in preference of non-invasive methods for diagnostics is driving the growth of the market. Moreover, the rising geriatric population, increasing prevalence of gastrointestinal diseases like colorectal cancer, changing lifestyle, increasing unhealthy eating habits, controlled drug delivery and better way of endoscopy procedures are major factors influencing the growth of the market.
Global Electronic Pill Market, by Key Players
  • CapsoVision, Inc. (US)
  • Given Imaging Ltd. (Israel)
  • Medimetrics (Mexico)
  • Bio-Images Drug Delivery BDD LTD (UK)
  • Proteus Digital Health (US)
  • Olympus Corporation
  • Medtronic
  • Medisafe
  • JINSHAN Science & Technology
  • INTROMEDIC
Segmentation
On the basis of region, the global Electronic Pill market is segmented into the Americas, Europe, Asia Pacific, and the Middle East and Africa.
The Americas is sub-segmented into North America and South America. The North American region is further segmented into the US and Canada. The European region is divided into two, namely, Western Europe and Eastern Europe. Western Europe is further classified into Germany, Italy, France, the U.K., Spain, and the rest of Western Europe. The Asia Pacific region is sub-segmented into Japan, China, India, Australia, the Republic of Korea, and the rest of Asia Pacific. The Middle Eastern and African region is sub-segmented into the United Arab Emirates, Saudi Arabia, Oman, Kuwait, Qatar, and the rest of the Middle East and Africa.
The global electronic pill market is segmented on the basis of Application, Target area, Parts and end user. The electronic pill market, by application, is sub-segmented into Capsule Endoscopy, Drug Delivery, and Patient Monitoring. Target area category includes Oesophagus, Stomach, Small Intestine, and large intestine.
By parts, the market is categorized into biocompatible capsule encasing microsensors, Control chip, Radio transmitter and Power source. On the basis of end-user, the market is segmented into Hospitals, Diagnostic centers, Clinical Research Organizations and Medical Centers.
Regional Market Summary
The Electronic Pill market is dominated by North America owing to rising prevalence of gastrointestinal disorders and high R&D investments within this region stimulate market growth. According to the US Investments in Medical and Health Research and Development in 2016, the United States invested total $171.8 billion in medical and health R&D and the investment increased by 20.6% from 2013 to 2016. Also, the rising adoption of technologically advanced systems for early diagnosis of gastrointestinal disorders influences the market growth in this region.
It is estimated that Europe stood second in the global Electronic Pill market. The increasing prevalence of gastric cancer is driving the growth of this market in Europe. According to the Cancer Research UK in 2015, 6740 new cases of stomach cancer in the U.K and is among the most common prevalent cancer. Thus, increasing prevalence of gastric cancer in Europe drives the market growth. Furthermore, the rapidly growing healthcare sector in Europe is expected to boost the market in this region.
Asia Pacific was projected to be the fastest growing region for the global Electronic Pill market. Key factors such as rising geriatric population, growing patient pool, high incidence of gastrointestinal diseases and developing healthcare infrastructure drive the market in this region. According to the Asian Development Bank (ADB), the geriatric population in Asia is expected to reach 923 million by 2050. This provides favorable backgrounds for the market to grow.
The Middle East and Africa holds the least share in the global Electronic Pill market due to the presence of stringent government policies and poor economic growth. However, growing awareness and increasing investment by private market players in this region can boost the market growth. 
Browse Complete 100 Pages Premium Research Report Enabled with 95 Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/electronic-pill-market-6204

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:

Insect Protein Market size and Key Trends in terms of volume and value 2018

Market Scenario:
The Global Insect Protein Market is expected to reach an approximate CAGR of 16.5% during the forecast period. The ever-rising population eventually leading to decrease in agricultural lands is likely to drive the market. According to the United Nations in 2017, the world population was 7.6 billion and is expected to reach 9.8 billion by 2050. Moreover, in 2015, the U.S. Census Bureau projected that the U.S. population would reach 417 million by 2060 that is a 38% increase as compared to 2007. The trend of protein-rich diet, the high cost of animal and plant-based proteins, and health awareness are other important factors influencing the growth of the market. For instance, house crickets contain 205 g/kg of protein on an average, whereas beef contains 256 g/kg. Similarly, mealworms contain unsaturated omega-3 and six fatty acids as much as fish and pork. With these benefits of insect proteins, the market is projected to grow rapidly.
However, factors such as stringent environmental regulations, risks associated (allergies) with insect consumption, psychological barriers, religious and cultural believes, and ethical issues are expected to hinder the market growth during the forecast period.
Global Insect Protein Market, by Key Players
  • Thailand Unique
  • Kreca Ento-Food
  • Nordic Insect Economy Ltd.
  • Entomo Farms Ltd.
  • Enviro Flight
  • Proti-Farm
  • Exo Inc.
  • Crik Nutrition
  • Deli Bugs Ltd.
  • Agriprotein Technologies
  • Bugsolutely
  • Hopper Foods
  • Hargol Food Tech
  • Griopro
  • Kric8
Segmentation
The global insect protein market is segmented on the basis of type, product type, application, and distribution channel. The insect protein market, by type, is segmented into crickets, mealworms, black soldier flies, grasshoppers, ants, silkworms, cicadas, and others. The product type segment is sub-segmented into whole insects, insect meals, insect powder, insect protein bars and protein shakes, insect baked products and snacks, insect confectionaries, insect beverages, insect oil, and others. The application segment is sub-segmented into human consumption, animal nutrition, and cosmetics and pharmaceutical. On the basis of distribution channel, the market is categorized into online portals and retail stores.
On the basis of region, the global insect protein market is segmented into the Americas, Europe, Asia Pacific, and the Middle East and Africa.
The Americas is sub-segmented into North America and South America. The North American region is further segmented into the U.S. and Canada. The European region is divided into two, namely, Western Europe and Eastern Europe. Western Europe is further classified into Germany, Italy, France, the U.K., Spain, and the rest of Western Europe. The Asia Pacific region is sub-segmented into Japan, China, India, Australia, the Republic of Korea, and the rest of Asia Pacific. The Middle Eastern and African region is sub-segmented into the United Arab Emirates, Saudi Arabia, Oman, Kuwait, Qatar, and the rest of the Middle East and Africa.
Regional Market Summary
The insect protein market is dominated by Asia Pacific owing to the huge increasing population.
The Americas will witness growth for the insect protein market owing to growing awareness and increasing nutrition demand.  The increase in the per capita meat consumption and fears of protein shortage fuel the market within the region.
Asia is the most populous of all the continents and has two most populous countries, China and India. According to World Population Review in 2017, China has the largest population in the world which is estimated to be 1,377,124,512, which is 31.69% of Asia's total population and 18% of the world's population. China is followed by India with an estimated population of 1,285,800,000 and accounts for 29.36% of the continent's population. With the growth in population, the need for healthy food alternatives is also growing. Moreover, insect harvesting, gathering, and processing is an important occupation in some countries of Asia. This drives the growth of the market in this region.
Europe is expected to be the second largest region in the global insect protein market. The EU regulation 2017, granted permission to use insect proteins as fish feed, thus offering a milestone for the European insect production sector. The increased production of insect feed in Europe for the aquaculture sector drives the growth of the market in Europe. The aquaculture sector has grown tremendously and is an important contributor to the region’s food production sector. According to Eurostat in 2017, aquaculture accounted for 19.7% of the total fisheries production and the amounted for EUR 4 billion. Thus, rapidly growing aquaculture sector provides favorable backgrounds for the market to grow in Europe.
The Middle East holds the least share in the global insect protein market due to the presence of stringent government policies. On the other hand, Africa holds a large share in the Middle Eastern and African region for the insect protein market, as the tradition of insect consumption is more than hundreds of years old. The rising price of beef and meat and the tropical climate for insect growth in this region also pose a huge opportunity for the market to grow in this region.
Browse Complete 100 Pages Premium Research Report Enabled with 96 Respective Tables and Figures at @ https://www.marketresearchfuture.com/reports/insect-protein-market-6094

       
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:

Worldwide Spinal Needles Market 2018 Outlook, top 10 Industry players comprehensive analysis and Forecast to 2023

Spinal needles are medical devices generally used in administration of drug or diagnostic purposes. Spinal needles are inserted into the spinal cord or canal for the collecting cerebrospinal fluid (CSF) for diagnostic testing purposes or drug administration for the treatment of any neurological disease, fractures or vertebroplasty. Spinal anaesthesia is done to temporarily numb the area of pain during spine surgery in which the spinal needles play an important role in the drug administration of anaesthesia. The global spinal needle market is expected to grow at a CAGR of 6.8% during the forecasted period 2017-2023.
Key Players
The key players in the global spinal needles market include Argon Medical Devices Inc (Netherland),  B. Braun (Germany), BD (USA), Boston Scientific (USA), Cook Medical (USA), Exel International (USA), Halyard Health (USA), Medline Industries (USA), Medtronic (UK), MYCO Medical (USA), Novo Nordisk (Denmark), Sarstedt (UK), Smiths Medical (USA), Stryker Corporation (USA), and Wallach Surgical (USA).
Latest Industry News
  • Abacus Finance Group LLC has provided senior debt financing to support Zavation Medical Products LLC’s acquisition of Tampa, Florida-based Pan Medical US Corp, a maker of medical products used in minimally invasive procedures. 22 OCT 2018
  • Two University of Virginia alumni have built a new spine-finding device that is giving the practice of identifying the correct insertion point for epidurals and other forms of spinal anesthesia, a much-needed upgrade. 14 JUNE 2018
Regional analysis
The regional segmentation of the global spinal needles market segments the market into continent-based regional markets namely The Americas (North America & South America), Asia Pacific, Europe, and the Middle East & Africa (MEA). The biggest regional market is The Americas. North America alone holds the potential to be the largest market due to its strong economies are known as the United States of America (USA) and Canada. Many key market players are based in the USA. In this region, the availability of advanced medical facilities makes North America a bigger market than South America. Factors supporting the market growth in this region include increasing awareness among the people, an increasing number of spinal surgeries, and the increasing prevalence of different neurological disease.
Decent technological advancement, increasing healthcare expenditure, rising prevalence of diseases, and well-developed healthcare sectors are the reasons that have made Europe the second largest regional market after North America. Due to the reasons same as The Americas, Western Europe is a bigger market than Eastern Europe. The significant country-specific markets in this region are France, Italy, Germany, the United Kingdom (UK), and Spain, followed by the rest of Western Europe and then Eastern Europe.
According to the report, Asia Pacific region is likely to witness a faster growth for the market during the forecast period. Factors contributing to the faster growth include the presence of huge patient population suffering from different infectious diseases and steadily rising quality of medical services in countries like India and Japan. Apart from these two countries, the other country-specific markets are Australia, South Korea, and China, followed by the rest of the Asia Pacific region. 
The MEA region shows limited market slow and steady growth. The reasons for the slow market growth in this region are lack of awareness, lack of education, lack of technological development, political instability, poor healthcare facilities, and healthcare not considered a priority by most governments. The primal country-specific markets in this region are Kuwait, Oman, Qatar, United Arab Emirates (UAE), and Saudi Arabia, followed by the rest of the MEA region.
Intended Audience 
  • Spinal needles manufacturers
  • Spinal needles suppliers
  • Research and Development (R&D) companies
  • Independent research laboratories
  • Market research and consulting service providers
  • Medical research laboratories
  • Academic medical institutes and universities
Segmentation
Global spinal needle market is segmented on the basis of type, application and end users.  On the basis of type, the market is segmented into atraumatic needle tips, directional spinal needles, pencil-point needles and others. On the basis of size, the market is segmented into 24G, 25G, 27G and other. On the basis of application, the market is segmented into diagnostic and therapeutic. And on the basis of end users, they are segmented into hospitals, clinics and other.
Browse Complete 80 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/spinal-needles-market-1216


About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:

Vocal Cord Paralysis Market Segmentation Detailed Study with Forecast Up To 2018

Market Scenario
Vocal cord paralysis is a medical condition where the nerves leading to the vocal cord is damaged resulting in dysphonia. It is also known as vocal fold paresis. The global vocal cord paralysis market is likely to reach a valuation of USD 2920.2 Mn at a CAGR of 3.8% over t5eh forecast period of 2018-2023, asserts Market Research Future (MRFR) in an extensive study. The growth of the global vocal cord paralysis market is sustained by the high prevalence of brain disorders which can cause vocal cord paralysis. Escalating cases of neck, head, and laryngeal cancers is a prime reason for the growth of the global vocal cord paralysis. Surgeries related to such disorders carry a high risk of causing damage to the vocal cord. Advancements in treatment procedures such as endoscopy, laryngoscopy, and others facilitate rapid diagnosis of the condition and thereby foster market growth. Other driving factors include increased healthcare expenditure, especially in developing countries. Improving reimbursement scenario across the globe encourages patients to opt for treatment which further stimulates the growth of the market. On the other hand, the growth of the global vocal cord paralysis market might be hindered by heavy costs associated with the treatment of the diseases which might limit the growth of the market in price-sensitive market.                                                                                                                                                                                                                                                                                                                                                                            Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/5079
Segmentation
The global vocal cord paralysis market has been segmented based on type and treatment.
By type, the global vocal cord paralysis market has been segmented into unilateral and bilateral. The unilateral segment accounts for the largest share of 89.3% of the global market. The segment is expected to attain a valuation of USD 2646.5 Mn at a CAGR of 3.6% over the forecast period. The bilateral segment is likely to be the fastest growing segment over the forecast period and register a CAGR of 3.8% over the forecast period.
By treatment, the global vocal cord paralysis market has been segmented into voice therapy and surgery. The surgery segment has been further segmented into structural implants, vocal cord repositioning (phonosurgery), bulk injection, and tracheotomy. The voice therapy holds the largest share of 62.8% of the global market and is expected to reach USD 1848.7 Mn by the end of the forecast period. The surgery segment is anticipated to be the fastest growing segment with a CAGR of 3.8% and reach USD 1121Mn by the end of the forecast period.
Regional Analysis
By region, the global vocal cord paralysis market has been segmented into the Americas, Asia Pacific (APAC), Europe, and the Middle East & Africa (MEA).
The Americas accounted for the largest share of 35.4% share of the global market in 2017 and is due to reach USD 1,007.5 Mn in 2023 at a CAGR of 3.4% by the end of the forecast period. Robust healthcare sector, technological superiority, and rising expenditure ion healthcare sector drive the market in the Americas. In addition, the region is highly aware of the medical condition which is acts a plus for the growth of the market.
Europe is a prominent market for vocal cord paralysis and is likely to scale valuation of USD 958.1 Mn at a CAGR of 4% by the end of the forecast period. Similar factors spur the Europe market as the Americas. Also, favorable reimbursement policies and high government support create a conducive environment for the growth of the Europe vocal cord paralysis market.
APAC vocal cord paralysis market is likely to exhibit rapid growth over the forecast period and emerge as the fastest growing market over the forecast period. The increasing prevalence of laryngeal cancer, availability of affordable treatment options and high expenditure on healthcare drive the market in APAC. The APAC market is expected to capture a CAGR of 4.11% over the forecast period.
The MEA market for vocal cord is expected to hold the least share of the market and expand at a CAGR of 3.90% over the forecast period.
Competitive Landscape
The key players operating in the global vocal cord paralysis market include LifeCell Corporation (U.S.), Teleflex Incorporated (U.S.), FUJIFILM Holdings Corporation (Japan), Smiths Group Plc (U.K.), KARL STORZ GmbH & Co. KG (Germany), Olympus Corporation (Japan), Stryker Corporation (U.S.), Therapy Solutions Inc. (U.S.), Cytophil, Inc. (U.S.), and Medtronic Plc (U.S.).l
Browse Complete 103 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/vocal-cord-paralysis-market-5079
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:

Cerebral Palsy Market size and Key Trends in terms of volume and value 2018

Market Scenario
Cerebral palsy (CP) is a congenital disorder that affects the muscle tone, movement, and motor skills. CP is generally considered to be caused by brain damage that happens before or during the baby's birth. The signs and symptoms of CP vary from person to person. According to the Centers for Disease Control and Prevention (CDC), some of the signs and symptoms of clinical palsy includes coordination and control problem, lack of muscle control, oral motor problems, and abnormal reflex responses. Currently, there are a wide variety of medications and therapies available to help people with cerebral palsy.
The increasing prevalence of cerebral palsy coupled with increasing awareness about the condition is anticipated to drive the global cerebral palsy market. According to an article published by the National Center for Biotechnology Information (NCBI) in 2017, the overall birth prevalence of cerebral palsy is approximately 2 per 1,000 births worldwide. Moreover, the rising adoptions of medications for controlling the symptoms of the cerebral palsy are expected to boost the market growth. In addition, rising healthcare expenditure in developed economies and increasing insurance coverage contributes to the growth of the market during the assessment period. On the other hand, side effects associated with medications and high treatment cost and lack of awareness in some developing regions may hinder the growth of the market.
Despite the drivers, side effects associated with medications and high treatment cost and lack of awareness in some developing regions may hamper the market growth during the assessment paeriod.
Segmentation
The global cerebral palsy market has been segmented into type, diagnosis, and treatment.
The market, on the basis of type, has been segmented into spastic cerebral palsy, dyskinetic cerebral palsy, hypotonic cerebral palsy, ataxic cerebral palsy, and mixed cerebral palsy.
The market, by diagnosis, has been segmented into imaging tests and others. The imaging tests have been further segmented into magnetic resonance imaging (MRI), cranial ultrasound, computed tomography, and electroencephalogram.
The market, by treatment, has been segmented into therapy, medication, surgery, and others. The therapy segment has been segmented into nutrition therapy, hyperbaric oxygen therapy, occupational therapy, physical therapy, stem cell therapy, and others. The medication segment has been segmented into anti-convulsant drugs, muscle relaxants, anti-depressant drugs, anti-inflammatory drugs, and others. Further, the surgery segment has been segmented into orthopedic surgery and others.
Key players
Allergen Plc, Cellular Biomedicine Group, Merck & Co., Inc., Pfizer, Inc., GlaxoSmithKline Plc, Abbott Laboratories, Acorda Therapeutics, Inc., Medtronic, Meridigen Biotech Co., Ltd., GW Pharmaceuticals Plc, and Cell Cure Neurosciences Ltd. are some of the key players in the global cerebral palsy market.
Regional Market Summary
Geographically, the Americas is anticipated to dominate the global cerebral palsy market owing to a well-developed healthcare sector, rising prevalence of cerebral palsy and growing healthcare expenditure. Additionally, favorable reimbursement scenario in this region and a relatively large number of research and development (R&D) activities contributes to the growth of the market.
Europe is expected to hold the second largest position in the global cerebral palsy market. The market growth in this region is attributed to the growing prevalence of cerebral palsy, availability of funds for research, and increasing healthcare expenditure. According to the data stated by the National Institute for Health and Care Excellence (NICE) in 2017, in the UK, it is estimated that 1 in 400 babies are born with cerebral palsy. It also stated that approximately 1,800 children diagnosed with CP each year.
The cerebral palsy market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. Asia-Pacific is anticipated to be the fastest growing region in the market due to the presence of a huge patient population, continuously developing economies, rising prevalence of cerebral palsy and increasing government funding for the healthcare sector.
On the other hand, the Middle East & Africa has the least share of the market. Majority of the market of this region is expected to be held by the Middle East region due to a well-developed healthcare sector and growing government initiatives for the healthcare sector.
Browse Complete 90 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/check-discount/6334   
  
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:

Thursday, 4 April 2019

Nasal Drug Delivery Market Pipeline Review, 2018- Identify Key Business Opportunities

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Labels:

Recent Study Explores Stroke Disorder and Treatment Market Pipeline Review, 2018

 
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Subscribe to: Posts (Atom)